Dr. Dr. Carl Sadowsky

Expert Publications

• A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.
• Safety and efficacy of rivastigmine in patients with Alzheimer's disease not responding adequately to donepezil: an open-label study.
• Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease.
• Alexia without agraphia, hemianopia, or color-naming defect: a disconnection syndrome.
• Alexia without agraphia, hemianopia, or color-naming defect: a disconnection syndrome.
• Use of florbetapir-PET for imaging beta-amyloid pathology.
• Switching from oral donepezil to rivastigmine transdermal patch in Alzheimer's disease: 20-week extension phase results.
• Practical guidelines for the recognition and diagnosis of dementia.
• Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
• Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
• Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals.
• Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.
• Alzheimer's disease diagnosis by detecting exogenous fluorescent signal of ligand bound to Beta amyloid in the lens of human eye: an exploratory study.
• A 24-week, randomized, controlled trial of rivastigmine patch 13.3 mg/24 h versus 4.6 mg/24 h in severe Alzheimer's dementia.
• A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer Disease.

Media Releases

Get to know Neurologist Dr. Carl Sadowsky, who serves patients in West Palm Beach, Florida.

Specializing in cognitive neurology, Dr. Sadowsky is the Director of Research at Premiere Research Institute in West Palm Beach, Florida. His focus is on memory loss and Alzheimer’s disease. 

Recognized as one of the leading clinical research institutions in the world, Premiere Research Institute is involved in multiple areas of cutting-edge research, including Alzheimer’s disease/memory loss, headache/migraine, multiple sclerosis, attention deficit disorder, and depression. With over 75 years of combined clinical experience, the physicians and staff working there are dedicated to providing innovative solutions for patients with neurological disorders all the while treating them with respect, empathy, and professionalism.

Alongside his clinical role, Dr. Sadowsky is a Clinical Professor within the Division of Neurology at Nova Southeastern University in Fort Lauderdale, Florida. He is also a board member of the Southeast Florida Alzheimer’s Association and was on the scientific review board for the Alzheimer’s Drug Discovery Foundation. 

A Fellow of the American Academy of Neurology (FAAN), the doctor is board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN). The ABPN is a not-for-profit corporation dedicated to promoting high quality patient care for the public through the initial and continuing certification of psychiatrists and neurologists. 

After graduating Summa Cum Laude with his Bachelor of Science (BS) degree in Biochemistry from SUNY at Stony Brook, Dr. Sadowsky went on to receive his medical degree from the Joan & Sanford I. Weill Medical College of Cornell University in New York City. He completed an internship and residency in internal medicine and a residency in neurology at Dartmouth-Hitchcock Medical Center in Hanover, New Hampshire, where he served as chief resident. He then served as a United States Air Force Major and Chief of Neurology of the United States Air Force Hospital in Wiesbaden, Germany from 1976 until 1979.

Throughout his line of work, Dr. Sadowsky has participated in numerous trials evaluating the safety and efficacy of various cholinesterase inhibitors in the treatment of Alzheimer’s Disease (AD), a primary focus of his research efforts. He is also a frequent presenter at medical meetings and symposia and a prolific writer. His articles, which have appeared in such prestigious journals as the Journal of the American Medical Association, Neurology, and Archives of Neurology, have most recently focused on comparisons of agents used in the treatment of patients with AD, the molecular mechanisms of AD, imaging in dementia, and ethical issues associated with patient care.

Neurology is a branch of medicine dealing with disorders of the nervous system. Neurologists are licensed medical specialists who diagnose and treat disorders that affect the brain, spinal cord, nerves, and muscles of patients. They examine a patient’s mental and physical status, conduct medical tests and scans, and evaluate the results to diagnose and treat the patient.

Among his career distinctions, Dr. Sadowsky is listed in Best Doctors in America and Best Doctors in America, Southeast Region. He is also the recipient of On-Time Doctor Award (2018) and Patients’ Choice Award (2018).

Recommended Articles

• What a Start-Up is Doing to Transform Alzheimer's Care

  One of the best characteristics of a well-planned start up is its ability to solve the problems of the world.  Whether it be in the realm of technology, medicine, or social media, startups have the unique advantage of operating with the use of a small yet agile team, as there are not nearly as many...

• Risk Factors for Levodopa-induced Dyskinesia in Parkinson’s Patients Study

  There are motor as well as some non-motor symptoms that characterize Parkinson's disease. Parkinon's causes rigidity, tremors, and motor disabilities, as well as non-motor symptoms, including anxiety and depression. The most effective treatment to control Parkinson’s systems to date is Levodopa....

• Researchers Discover Algorithm for Early Diagnosis of Parkinson’s Disease

  Parkinson’s disease is a type of condition that affects the brain wherein a low level of dopamine would limit the person’s movement. This low dopamine level would be the main cause of Parkinson’s disease as a whole, although it is still not known as to what causes the low levels of dopamine in...

• The Easiest Ways to Relieve MS Discomfort

  Are you suffering from MS pain and discomfort? You are not alone. More than 50% of individuals with MS experience pain at some point in their lives. MS pain and discomfort varies from individual to individual and it can change over time. The impact that such symptoms can have on your quality of...

• Epilepsy and Its Effects On the Body

  Epilepsy is a chronic neurological disorder with seizures as its main symptom.Epilepsy in the Body: What are the Effects?Epilepsy is a common brain disorder affecting almost three million Americans. This condition can be caused by an injury or illness but most cases have no known cause. Epilepsy is...

• What Is Normal Pressure Hydrocephalus?

  Normal pressure hydrocephalus (NPH) is a type of brain disorder, wherein excess cerebrospinal fluid builds up in the ventricles of the brain. It causes problems in reasoning, thinking, difficulty in walking, and loss of bladder control.Brains ventricles are hollow fluid-filled chambers. Even...